Resolved

MINT-GABAPENTIN

MINT PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MINT-GABAPENTIN in Canada?

Not currently. The most recent shortage report for MINT-GABAPENTIN 300MG is marked resolved (last updated June 12, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength300MG

Last updated2026-06-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02408899

Strength

300MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

GABAPENTIN

Tier

Unrated

Last Updated

2026-06-12

Reason for Shortage

Requirements related to complying with good manufacturing practices.

Source

View original report on healthproductshortages.ca ↗

Other Products from MINT PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

300MG · DIN 02480956

10MG · DIN 02468840

25MG · DIN 02468859

400MG · DIN 02524716

800MG · DIN 02524724

200MG · DIN 02524708